Vanessa Conri

About

Dr. Vanessa Conri is a leading figure in gynecologic oncology, whose research has fundamentally shaped the evidence base for minimally invasive surgery. Her work centers on a critical comparison between robot-assisted laparoscopy (RL) and conventional laparoscopy (CL), with a primary focus on patient safety and surgical outcomes. Dr. Conri’s most impactful contribution is the landmark **ROBOGYN-1004 trial**, a randomized study that directly assessed severe perioperative morbidity between these two approaches. Her seminal 2020 paper detailing these results has garnered **34 citations**, establishing a key benchmark for the field. Further solidifying her expertise, her 2015 work on robotically assisted para-aortic lymphadenectomy (with **30 citations**) remains a foundational technical reference. Demonstrating her commitment to nuanced analysis, Dr. Conri’s 2024 study delves into the secondary findings of the ROBOGYN-1004 trial, exploring how surgical complexity and institutional experience influence patient outcomes. Through this rigorous body of work, Dr. Conri has provided surgeons with essential data to guide operative decision-making, directly improving the safety and efficacy of surgical care for women with gynecologic cancers.

Research Focus

Key Achievements

Top Papers

1. 1
   Severe perioperative morbidity after robot-assisted versus conventional laparoscopy in gynecologic oncology: Results of the randomized ROBOGYN-1004 trial

   34 citations · 2020
2. 2
   Robotically Assisted Para-aortic Lymphadenectomy: Surgical Results

   30 citations · 2015
3. 3
   The Influence of Surgical Complexity and Center Experience on Postoperative Morbidity After Minimally Invasive Surgery in Gynecologic Oncology: Lessons Learned from the ROBOGYN-1004 Trial

   2 citations · 2024

Key Collaborators

Contact & Links